BDBM50559812 CHEMBL4740375

SMILES COc1ccc(cc1)C1CNC(=O)C1NC(=O)Nc1ccc(Cl)cc1

InChI Key InChIKey=KHWQLQMKSMNUBQ-UHFFFAOYSA-N

Data  4 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50559812   

TargetN-formyl peptide receptor 2(Human)
Kyorin Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50559812(CHEMBL4740375)
Affinity DataEC50:  4.60nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Kyorin Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50559812(CHEMBL4740375)
Affinity DataEC50:  4.60nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Kyorin Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50559812(CHEMBL4740375)
Affinity DataEC50:  950nMAssay Description:Agonist activity at human FPR1 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Kyorin Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50559812(CHEMBL4740375)
Affinity DataEC50:  950nMAssay Description:Agonist activity at human FPR1 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed